{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:44:52Z","timestamp":1790693092716,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.prostaglandins.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T19:15:58Z","timestamp":1405019758000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["6-Iodolactone, key mediator of antitumoral properties of iodine"],"prefix":"10.1016","volume":"112","author":[{"given":"Mario","family":"Nava-Villalba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aceves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prostaglandins.2014.07.001_bib0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/thy.2012.0579","article-title":"The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues","volume":"23","author":"Aceves","year":"2013","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.prostaglandins.2014.07.001_bib0010","first-page":"177","article-title":"Iodine in mammary and prostate pathologies","volume":"5","author":"Anguiano","year":"2011","journal-title":"Curr Chem Biol"},{"issue":"28","key":"10.1016\/j.prostaglandins.2014.07.001_bib0015","first-page":"19762","article-title":"Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitocondria-mediated pathway","volume":"281","author":"Shrivastava","year":"2006","journal-title":"J Biol Quem"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0020","series-title":"Pro-oxidant reactions: physiological and pathological implications","first-page":"241","article-title":"The other face of iodine: a protective free radical?","author":"Alfaro-Hern\u00e1ndez","year":"2009"},{"issue":"14","key":"10.1016\/j.prostaglandins.2014.07.001_bib0025","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.lfs.2005.05.013","article-title":"Lipids as bioeffectors in the immune system","volume":"77","author":"Cabral","year":"2005","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1389557053402828","article-title":"Lactones: generic inhibitors of enzymes?","volume":"5","author":"Konaklieva","year":"2005","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0035","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2010.06.018","article-title":"What are nuclear receptor ligands?","volume":"334","author":"Sladek","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0045","series-title":"Comprehensive organic name reactions and reagents","first-page":"1521","article-title":"Iodolactonization","author":"Wang","year":"2009"},{"issue":"21","key":"10.1016\/j.prostaglandins.2014.07.001_bib0050","first-page":"864","article-title":"Action de l\u2019iode et l\u2019oxyde jaune de mercure sur les acides \u00e0 fonction \u00e9thyl\u00e9nique. S\u00e9paration des isom\u00e8res","volume":"139","author":"Bougault","year":"1904","journal-title":"C R Acad Sci"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0055","first-page":"296","article-title":"Action de l\u2019acide hypoiodeux naissant sur les acides non satur\u00e9s","volume":"15","author":"Bougault","year":"1908","journal-title":"Ann Chim Phys"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0060","first-page":"145","article-title":"Action de l\u2019acide hypoiodeux naissant sur les acides non satur\u00e9s. Lactones iod\u00e9es","volume":"14","author":"Bougault","year":"1908","journal-title":"Ann Chim Phys"},{"issue":"20","key":"10.1016\/j.prostaglandins.2014.07.001_bib0065","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1021\/ja01048a062","article-title":"Stereo-controlled synthesis of prostaglandins F-2a and E2 (dl)","volume":"91","author":"Corey","year":"1969","journal-title":"J Am Chem Soc"},{"issue":"18","key":"10.1016\/j.prostaglandins.2014.07.001_bib0070","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1021\/ja00460a038","article-title":"The total synthesis of dl-vernolepin and dl-vernomenin","volume":"99","author":"Danishefsky","year":"1977","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10.1016\/j.prostaglandins.2014.07.001_bib0075","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/ol800118c","article-title":"Synthesis of (+\/\u2212)-vibralactone","volume":"10","author":"Zhou","year":"2008","journal-title":"Org Lett"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0005-2760(83)90173-X","article-title":"Iodination of arachidonic acid mediated by eosinophil peroxidase, myeloperoxidase and lactoperoxidase. Identification and comparison of products","volume":"751","author":"Turk","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0085","series-title":"The thyroid. A fundamental and clinical text","first-page":"85","article-title":"Autoregulatory actions of iodine","author":"Pisarev","year":"2000"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0090","series-title":"Comprehensive handbook of iodine. Nutritional, biochemical, pathological and therapeutic aspects","first-page":"243","article-title":"Autoregulation of thyroid growth and function by iodine: independent regulation of the thyroid gland by iodocompounds","author":"G\u00e4rtner","year":"2009"},{"issue":"19","key":"10.1016\/j.prostaglandins.2014.07.001_bib0095","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1016\/S0021-9258(19)70513-4","article-title":"Transformation of arachidonic acid into an iodolactone by the rat thyroid","volume":"255","author":"Boeynaems","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0100","series-title":"Comprehensive handbook of iodine. Nutritional, biochemical, pathological and therapeutic aspects","first-page":"303","article-title":"Iodide effects on the thyroid: biochemical, physiological, pharmacological, and clinical effects of iodide in the thyroid","author":"Panneels","year":"2009"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1210\/endo-127-1-337","article-title":"Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3\u2032,5\u2032-monophosphate formation","volume":"127","author":"Dugrillon","year":"1990","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02537238","article-title":"Iodination of arachidonic acid by the iron\/H2O2\/iodide system","volume":"18","author":"Henderson","year":"1983","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0115","first-page":"31","article-title":"Synthesis and characterization of iodinated derivatives of arachidonic acid","volume":"78","author":"Monteagudo","year":"1990","journal-title":"An Asoc Quim Argent"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0021-9258(18)57335-X","article-title":"Plasma inorganic iodide as a homeostatic regulator of thyroid function","volume":"174","author":"Wolff","year":"1948","journal-title":"J Biol Chem"},{"issue":"9\u201310","key":"10.1016\/j.prostaglandins.2014.07.001_bib0125","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1089\/ars.2006.8.1563","article-title":"Physiology and pathophysiology of the DUOXes","volume":"8","author":"Ris-Stalpers","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1016\/j.prostaglandins.2014.07.001_bib0130","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/endo.140.8.6893","article-title":"Escape from the acute Wolff\u2013Chaikoff effect is associated with a decrease in thyroid sodium\/iodide symporter messenger ribonucleic acid and protein","volume":"140","author":"Eng","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1172\/JCI106225","article-title":"Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis","volume":"49","author":"Wartofsky","year":"1970","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1530\/acta.0.1050040","article-title":"Vascularization and iodide transport down regulation in rat goitre","volume":"105","author":"Rognoni","year":"1984","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0145","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/jcem-73-5-1051","article-title":"Inverse relation between iodine intake and thyroid blood flow: color Doppler flow imaging in euthyroid humans","volume":"73","author":"Arntzenius","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0150","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/endo-90-5-1409","article-title":"Action of KI on stimulated thyroid protein biosynthesis","volume":"90","author":"Pisarev","year":"1972","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0155","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1210\/endo.141.2.7291","article-title":"Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress","volume":"141","author":"Vitale","year":"2000","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/thy.2000.10.123","article-title":"Excess iodine induces apoptosis in the thyroid of goitrogen-pretreated rats in vivo","volume":"10","author":"Burikhanov","year":"2000","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0304-4165(73)90031-7","article-title":"Effects of thyrotropin, prostaglandin E1 and iodide on cyclic 3\u2032,5\u2032-AMP concentration in dog thyroid slices","volume":"313","author":"Van Sande","year":"1973","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(77)80635-2","article-title":"Inhibition of thyroid adenylate cyclase by iodide","volume":"83","author":"Pochet","year":"1977","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.prostaglandins.2014.07.001_bib0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/endo-96-3-781","article-title":"Inhibition by iodide of the activation of the thyroid cyclic 3\u2032,5\u2032-AMP system","volume":"96","author":"Van Sande","year":"1975","journal-title":"Endocrinology"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0180","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1530\/eje.0.1320733","article-title":"Which iodolipids are involved in thyroid autoregulation: iodolactones or iodoaldehydes?","volume":"132","author":"Boeynaems","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0029-1211700","article-title":"Iodolactones and iodoaldehydes\u2014mediators of iodine in thyroid autoregulation","volume":"104","author":"Dugrillon","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0021-9258(18)70756-4","article-title":"An unidentified iodine compound formed by incubation of cell-free preparations of tissue with iodide-I[131]","volume":"227","author":"Taurog","year":"1957","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0195","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0021-9258(18)69418-9","article-title":"Iodide binding in thyroid cellular fractions","volume":"235","author":"DeGroot","year":"1960","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0003-9861(62)90100-5","article-title":"An iodide-complexing phospholipid","volume":"97","author":"Vilkki","year":"1962","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.prostaglandins.2014.07.001_bib0205","first-page":"971","article-title":"On the iodinated lipids of the thyroid gland and their possible participation in hormogenesis","volume":"157","author":"Mauchamp","year":"1963","journal-title":"C R Seances Soc Biol Fil"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0014-4827(67)90241-8","article-title":"Metabolic properties of isolated sheep thyroid cells","volume":"47","author":"Rodesch","year":"1967","journal-title":"Exp Cell Res"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0215","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1530\/acta.0.0700683","article-title":"Iodinated thyrolipids","volume":"70","author":"Shah","year":"1972","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"10.1016\/j.prostaglandins.2014.07.001_bib0220","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1042\/bj1920801","article-title":"Intracellular and extracellular sites of iodination in dispersed hog thyroid cells","volume":"192","author":"Rousset","year":"1980","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0225","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0926-6585(65)90014-2","article-title":"Thyroidal iodide transport VI. On a possible role for iodide-binding phospholipids","volume":"94","author":"Schneider","year":"1965","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0230","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0005-2760(69)90060-5","article-title":"Lipid-iodine association in the rat thyroid gland","volume":"187","author":"Posner","year":"1969","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.prostaglandins.2014.07.001_bib0235","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/acta.0.0740461","article-title":"Iodinated thyrolipids: their possible role in hormonogenesis","volume":"74","author":"Shah","year":"1973","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0240","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF02535024","article-title":"Lactoperoxidase-catalyzed iodination of arachidonic acid: formation of macrolides","volume":"16","author":"Boeynaems","year":"1981","journal-title":"Lipids"},{"issue":"6","key":"10.1016\/j.prostaglandins.2014.07.001_bib0245","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.0.1320735","article-title":"delta-Iodolactones decrease epidermal growth factor-induced proliferation and inositol-1,4,5-trisphosphate generation in porcine thyroid follicles \u2013 a possible mechanism of growth inhibition by iodide","volume":"132","author":"Dugrillon","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.prostaglandins.2014.07.001_bib0250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2003-42721","article-title":"Influence of iodide and iodolactones on thyroid apoptosis. Evidence that apoptosis induced by iodide is mediated by iodolactones in intact porcine thyroid follicles","volume":"111","author":"Langer","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14310\/horm.2002.1254","article-title":"The role of iodine and delta-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells","volume":"9","author":"G\u00e4rtner","year":"2010","journal-title":"Hormones (Athens)"},{"issue":"28","key":"10.1016\/j.prostaglandins.2014.07.001_bib0260","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1016\/S0021-9258(17)44862-9","article-title":"Identification of a major iodolipid from the horse thyroid gland as 2-iodohexadecanal","volume":"265","author":"Pereira","year":"1990","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0303-7207(94)90110-4","article-title":"Inhibition of H2O2 production by iodoaldehydes in cultured dog thyroid cells","volume":"102","author":"Panneels","year":"1994","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.mce.2009.12.026","article-title":"Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by 2-iodohexadecanal","volume":"317","author":"Thomasz","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0275","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0303-7207(94)90184-8","article-title":"Inhibition of human thyroid adenylyl cyclase by 2-iodoaldehydes","volume":"106","author":"Panneels","year":"1994","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0280","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mce.2010.03.012","article-title":"6 Iodo-\u03b4-lactone reproduces many but not all the effects of iodide","volume":"323","author":"Thomasz","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0285","first-page":"367","article-title":"In vitro inhibitory effects of an iodinated derivative of arachidonic acid on calf thyroid","volume":"34","author":"Chazenbalk","year":"1984","journal-title":"Acta Physiol Pharmacol Latinoam"},{"issue":"9","key":"10.1016\/j.prostaglandins.2014.07.001_bib0290","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/BF03350212","article-title":"Thyroid autoregulation. Inhibition of goiter growth and of cyclic AMP formation in rat thyroid by iodinated derivatives of arachidonic acid","volume":"11","author":"Pisarev","year":"1988","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0303-7207(94)90156-2","article-title":"Inhibition of thyroid NADPH-oxidase by 2-iodohexadecanal in a cell-free system","volume":"99","author":"Ohayon","year":"1994","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0090-6980(88)90303-6","article-title":"Thyroid autoregulation. Inhibitory effects of iodinated derivatives of arachidonic acid on iodine metabolism","volume":"36","author":"Chazenbalk","year":"1988","journal-title":"Prostaglandins"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0305","first-page":"27","article-title":"Further studies on the antigoitrogenic action of iodoarachidonates","volume":"4","author":"Pisarev","year":"1992","journal-title":"Thyroidology"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(94)90054-X","article-title":"Studies on the goiter inhibiting action of iodolactones","volume":"258","author":"Pisarev","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.prostaglandins.2014.07.001_bib0315","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2007-1003687","article-title":"Thyroid autoregulation: evidence for an action of iodoarachidonates and iodide at the cell membrane level","volume":"23","author":"Krawiec","year":"1991","journal-title":"Horm Metab Res"},{"issue":"12","key":"10.1016\/j.prostaglandins.2014.07.001_bib0320","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1055\/s-2007-1003389","article-title":"Effect of iodoarachidonates on thyroid FRTL-5 cells growth","volume":"24","author":"Pisarev","year":"1992","journal-title":"Horm Metab Res"},{"issue":"10","key":"10.1016\/j.prostaglandins.2014.07.001_bib0325","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-2007-1001734","article-title":"Identification of delta-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles","volume":"26","author":"Dugrillon","year":"1994","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0330","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1530\/acta.0.1080072","article-title":"Biosynthesis and regulation of iodolipids in calf thyroid","volume":"108","author":"Chazenbalk","year":"1985","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0335","first-page":"47","article-title":"Evidence that iodolactones are the mediators of growth inhibition by iodine on the thyroid","volume":"23","author":"G\u00e4rtner","year":"1996","journal-title":"Acta Med Austriaca"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0340","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1677\/ERC-08-0125","article-title":"Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects","volume":"15","author":"Arroyo-Helguera","year":"2008","journal-title":"Endocr Relat Cancer"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0345","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prostaglandins.2009.04.001","article-title":"A complex between 6-iodolactone and the peroxisome proliferator-activated receptor type gamma may mediate the antineoplastic effect of iodine in mammary cancer","volume":"89","author":"Nu\u00f1ez-Anita","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"15","key":"10.1016\/j.prostaglandins.2014.07.001_bib0350","doi-asserted-by":"crossref","first-page":"8519","DOI":"10.1073\/pnas.140217197","article-title":"Retinoic acid induces sodium\/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line","volume":"97","author":"Kogai","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0355","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1677\/erc.1.01250","article-title":"Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line","volume":"13","author":"Arroyo-Helguera","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-4598-8-33","article-title":"Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)","volume":"8","author":"Aceves","year":"2009","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc1254","article-title":"Peroxisome-proliferator-activated receptors and cancers: complex stories","volume":"4","author":"Michalik","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.prostaglandins.2014.07.001_bib0370","doi-asserted-by":"crossref","first-page":"102737","DOI":"10.1155\/2008\/102737","article-title":"The role of PPARs in cancer","volume":"2008","author":"Tachibana","year":"2008","journal-title":"PPAR Res"},{"issue":"7","key":"10.1016\/j.prostaglandins.2014.07.001_bib0375","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2174\/156800911796798931","article-title":"Peroxisome proliferator-activated receptors: role of isoform gamma in the antineoplastic effect of iodine in mammary cancer","volume":"11","author":"Nunez-Anita","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0380","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1006\/bbrc.2001.5491","article-title":"Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators","volume":"286","author":"Yin","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.prostaglandins.2014.07.001_bib0385","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1158\/0008-5472.CAN-04-3990","article-title":"Peroxisome proliferator-activated receptor delta and gamma agonists differentially alter tumor differentiation and progression during mammary carcinogenesis","volume":"65","author":"Yin","year":"2005","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.prostaglandins.2014.07.001_bib0390","first-page":"5926","article-title":"Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells","volume":"63","author":"Lapillonne","year":"2003","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.prostaglandins.2014.07.001_bib0395","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0400","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1517\/13543784.2014.884708","article-title":"A new dawn for the use of thiazolidinediones in cancer therapy","volume":"23","author":"Joshi","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"10.1016\/j.prostaglandins.2014.07.001_bib0405","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2014.07.001_bib0410","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-4274(00)00265-4","article-title":"Characterization of peroxisome proliferator-activated receptor alpha in normal rat mammary gland and 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine-induced mammary gland tumors from rats fed high and low fat diets","volume":"118","author":"Roberts-Thomson","year":"2000","journal-title":"Toxicol Lett"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0415","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/mc.10061","article-title":"Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231","volume":"34","author":"Suchanek","year":"2002","journal-title":"Mol Carcinog"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0420","first-page":"1013","article-title":"Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element","volume":"16","author":"Pineda Torra","year":"2002","journal-title":"Mol Endocrinol"},{"issue":"12","key":"10.1016\/j.prostaglandins.2014.07.001_bib0425","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1158\/1535-7163.MCT-10-0570","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial\u2013mesenchymal transition","volume":"9","author":"Reka","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0430","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopha.2010.10.004","article-title":"Drug resistant MCF-7 cells exhibit epithelial\u2013mesenchymal transition gene expression pattern","volume":"65","author":"I\u015feri","year":"2011","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.prostaglandins.2014.07.001_bib0435","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1097-2765(00)80047-7","article-title":"Terminal differentiation of human breast cancer through PPAR gamma","volume":"1","author":"Mueller","year":"1998","journal-title":"Mol Cell"},{"issue":"7","key":"10.1016\/j.prostaglandins.2014.07.001_bib0440","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1055\/s-0029-1225615","article-title":"Antiproliferative\/cytotoxic activity of molecular iodine and iodolactones in various human carcinoma cell lines. No interfering with EGF-signaling, but evidence for apoptosis","volume":"118","author":"R\u00f6sner","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0445","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.plefa.2013.01.002","article-title":"6 Iodo-\u03b4-lactone: a derivative of arachidonic acid with antitumor effects in HT-29 colon cancer cells","volume":"88","author":"Thomasz","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pros.22536","article-title":"Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines","volume":"73","author":"Aranda","year":"2013","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0455","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0272-0590(90)90164-F","article-title":"Differences in the distribution of iodine and iodide in the Sprague-Dawley rat","volume":"15","author":"Thrall","year":"1990","journal-title":"Fundam Appl Toxicol"},{"issue":"3","key":"10.1016\/j.prostaglandins.2014.07.001_bib0460","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/15287399209531682","article-title":"Distribution of iodine into blood components of the Sprague-Dawley rat differs with the chemical form administered","volume":"37","author":"Thrall","year":"1992","journal-title":"J Toxicol Environ Health"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0465","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-4157(93)90017-I","article-title":"Iodide transport in the thyroid gland","volume":"1154","author":"Carrasco","year":"1993","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0470","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1210\/jcem.83.5.4839","article-title":"Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa","volume":"83","author":"Spitzweg","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.prostaglandins.2014.07.001_bib0475","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/thy.2007.0122","article-title":"Uptake and gene expression with antitumoral doses of iodine in thyroid and mammary gland: evidence that chronic administration has no harmful effects","volume":"17","author":"Anguiano","year":"2007","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.prostaglandins.2014.07.001_bib0480","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1008925301459","article-title":"Hypothesis: iodine, selenium and the development of breast cancer","volume":"11","author":"Cann","year":"2000","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0485","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1075-122X.2004.21341.x","article-title":"The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia","volume":"10","author":"Kessler","year":"2004","journal-title":"Breast J"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0490","first-page":"453","article-title":"Iodine replacement in fibrocystic disease of the breast","volume":"36","author":"Ghent","year":"1993","journal-title":"Can J Surg"},{"issue":"8","key":"10.1016\/j.prostaglandins.2014.07.001_bib0495","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eimc.2009.07.009","article-title":"100 years of Dr. Ehrlich's magic bullet (1909\u20132009)","volume":"28","author":"Garc\u00eda-S\u00e1nchez","year":"2010","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"6","key":"10.1016\/j.prostaglandins.2014.07.001_bib0500","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich's magic bullet concept: 100 years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.prostaglandins.2014.07.001_bib0505","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1081\/CNV-100107745","article-title":"Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments","volume":"19","author":"Dillman","year":"2001","journal-title":"Cancer Invest"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0510","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2125.2008.03187.x","article-title":"The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?","volume":"66","author":"Newsome","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"22","key":"10.1016\/j.prostaglandins.2014.07.001_bib0515","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2174\/0929867311320220003","article-title":"The fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcome","volume":"20","author":"Moros","year":"2013","journal-title":"Curr Med Chem"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0520","first-page":"977","article-title":"Biochemical characteristics of mammary glands and mammary tumors of rats induced by 3-methylcholanthrene and 7,12-dimethylbenz(a)anthracene","volume":"29","author":"Hilf","year":"1969","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0525","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0161-4630(78)90074-5","article-title":"Arachidonic acid distribution in lipids of mammary glands and DMBA-induced tumors of rats","volume":"1","author":"Rillema","year":"1978","journal-title":"Postraglandins Med"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0530","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0006-291X(03)00265-1","article-title":"Fatty acids synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains","volume":"302","author":"Swinnen","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.prostaglandins.2014.07.001_bib0535","first-page":"1061","article-title":"Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells","volume":"64","author":"Rolland","year":"1980","journal-title":"J Natl Cancer Inst"},{"issue":"2 Pt. 1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0540","first-page":"426","article-title":"Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells","volume":"39","author":"Wicha","year":"1979","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.prostaglandins.2014.07.001_bib0545","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jcb.10708","article-title":"Fatty acid synthase: a metabolic oncogene in prostate cancer?","volume":"91","author":"Baron","year":"2004","journal-title":"J Cell Biochem"},{"issue":"4","key":"10.1016\/j.prostaglandins.2014.07.001_bib0550","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ijo.2012.1588","article-title":"Arachidonic acid metabolism in human prostate cancer","volume":"41","author":"Yang","year":"2012","journal-title":"Int J Oncol"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882314000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882314000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T21:54:44Z","timestamp":1649627684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882314000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":110,"alternative-id":["S1098882314000288"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2014.07.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-Iodolactone, key mediator of antitumoral properties of iodine","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}